Last Updated: 25/03/2025
Predicting the impact of antimalarial resistance in West African parasites
Objectives
In this project African resistance mutations will be introduced into culture-adapted parasites from circulating infections in Ghana (West Africa). This will enable predictions to be made about how these specific mutations will affect drug treatment regimen in West Africa.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Malaria causes significant morbidity and mortality. The majority of the disease burden is in Africa. Resistance to the frontline antimalarial artemisinin has developed in Southeast Asia and is now present in East but not West Africa.
External reference
Themes
Date
Jan 2025 — Dec 2027
Total Project Funding
$865,800
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 2037527
AUD 1.32M
Project Site
Related Resources
